During the past decade, Commonwealth Cancer Center-Corbin conducted 126 clinical trials. In the 10-year time frame, 126 clinical trials started and 42 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 39 clinical trials were completed. i.e. 73.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Commonwealth Cancer Center-Corbin" #1 sponsor was "National Cancer Institute (NCI)" with 70 trials, followed by "SWOG Cancer Research Network" with 29 trials sponsored, "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Commonwealth Cancer Center-Corbin" #1 collaborator was "National Cancer Institute (NCI)" with 77 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Commonwealth Cancer Center-Corbin" are "Recurrent Ovarian Carcinoma" (7 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Invasive Breast Carcinoma" (6 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials). Many other conditions were trialed in "Commonwealth Cancer Center-Corbin" in a lesser frequency.

Most popular intervention types in "Commonwealth Cancer Center-Corbin" are "Drug" (116 trials), "Other" (89 trials), "Biological" (67 trials), "Procedure" (42 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (43 trials), "Quality-of-Life Assessment" (35 trials), "Computed Tomography" (25 trials), "Nivolumab" (24 trials) and "Questionnaire Administration" (24 trials). Other intervention names were less common.

The vast majority of trials in "Commonwealth Cancer Center-Corbin" are 121 trials for "All" genders, 24 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Commonwealth Cancer Center-Corbin". undefined are not yet recruiting, 53 are recruiting, 71 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Commonwealth Cancer Center-Corbin, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Commonwealth Cancer Center-Corbin, 3 "Phase 1" clinical trials were conducted, 77 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".